🔗 Share this article

The Nobel Prize in medical science was granted for transformative discoveries that clarify how the body's defense network attacks dangerous infections while sparing the healthy tissues.

A trio of esteemed scientists—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

The work identified specialized "sentinels" within the immune system that eliminate rogue immune cells that could harming the organism.

The discoveries are now enabling new therapies for autoimmune diseases and cancer.

These laureates will share a monetary award valued at 11 million SEK.

Decisive Findings

"The work has been essential for comprehending how the immune system functions and the reason we do not all develop severe self-attack conditions," stated the chair of the Nobel Committee.

This team's research explain a core question: In what way does the immune system protect us from numerous invaders while keeping our healthy cells unharmed?

Our immune system uses white blood cells that scan for indicators of infection, including pathogens and germs it has never encountered.

These defenders utilize detectors—called recognition units—that are produced by chance in countless variations.

That provides the defense network the capacity to combat a broad range of invaders, but the unpredictability of the process inevitably creates white blood cells that can attack the host.

Protectors of the Body

Researchers previously understood that a portion of these harmful white blood cells were destroyed in the immune organ—the site where white blood cells develop.

The latest Nobel Prize recognizes the identification of T-reg cells—known as the body's "security guards"—which travel through the body to neutralize any immune cells that attack the body's own tissues.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and RA.

The prize committee stated, "The discoveries have laid the foundation for a new field of research and accelerated the development of innovative therapies, for example for cancer and autoimmune diseases."

Regarding malignancies, T-regs block the body from attacking the tumor, so research are aimed at lowering their numbers.

In self-attack disorders, experiments are exploring increasing regulatory T-cells so the body is not under attack. A comparable approach could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Studies

Prof Shimon Sakaguchi, of a Japanese institution, conducted tests on rodents that had their thymus removed, leading to autoimmune disease.

The researcher showed that injecting defense cells from other animals could prevent the illness—suggesting there was a mechanism for blocking defenders from attacking the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and humans that resulted in the identification of a genetic factor critical for how regulatory T-cells function.

"The groundbreaking work has uncovered how the immune system is controlled by T-reg cells, stopping it from mistakenly targeting the healthy cells," said a leading physiology specialist.

"This research is a striking illustration of how fundamental physiological study can have broad implications for public health."